Follow Us
Cancer and HIV

Kaposi Sarcoma

The Latest

Promo Image

Transmission of Human Herpes Virus Type 8 (HHV-8, The Kaposi's Sarcoma-Associated Herpes Virus)

Although it has been over five years since the initial reports of a virus related to KS were made, it is still unclear just how this virus is transmitted. Studies by various investigators have shown a clear and fairly striking relationship between th...

Starting HIV Treatment Early Reduces HIV-Related Cancer Risk by 74% Img

Starting HIV Treatment Early Reduces HIV-Related Cancer Risk by 74%

Starting HIV treatment soon after diagnosis may reduce the risk of developing HIV-related cancer by 74%, according to a recent study.

Promo Image

Kaposi's Sarcoma

What Is KS? How Is KS Treated? Can KS Be Prevented? What Else Is Being Studied for KS? The Bottom Line

What Is KS?

Kaposi's sarcoma (KS) is a cancer-like disease. It originally was known as a disease affecting elderly men of Eastern Europ...

Promo Image

An Overview of Doxorubicin Hydrochloride (Doxil)

LIP-oh-som-al dox-oh-ROO-bi-sin

Brand Name: Doxil Other Name(s): Adriablastin, Adriablastine, Adriamycin, Adriblastin, Caelyx, Clorhidrato de doxorrubicina liposómica, Doxorubicin Hydrochloride, Doxorubicin hydrochloride (liposomal), Doxorubicina, L...

Promo Image

Wide-Ranging Progress on KS Therapies

A few years ago, about 9,000 cases a year of HIV-related Kaposi's sarcoma (KS) were diagnosed in the U.S. Potent anti-HIV therapies may now be decreasing the annual rate of new cases, but there are still 25,000 Americans living with AIDS KS today. Th...

Promo Image

New Anti-HIV Vaccine and KS Trials at the National Cancer Institute

The Adult Clinical AIDS Program in the National Cancer Institute is presently recruiting for the following clinical trials for HIV infection and Kaposi's sarcoma (KS). Dr. Robert Yarchoan is the Principal Investigator for these trials:

Protocols for...

Promo Image

FDA Recommends DOX-SL for Accelerated Approval

Michael Marco reports back from FDA-land, where there is always a story to tell, and usually more than one way to tell it. He dedicates this his latest reportage to the memory of fellow treatment warrior Jesse Dobson, who died last fall, on September...